NTcell group would need to show clear markers of improvement, as if both groups faired poorly it wouldnt matter if the implant was merely less worse than the placebo
the placebo group does not have to fair well, it merely should not show same improved markers to the extent the NTcell group shows
Passing Through the 20's, page-114
-
- There are more pages in this discussion • 65 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $11.81M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.8¢ | 0.6¢ | $13.57K | 1.955M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 49537 | 0.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.8¢ | 2398744 | 13 |
View Market Depth
| Last trade - 14.21pm 30/09/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |